- Filed
- Apr 28, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 10.99M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $72.88M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $71.42M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $91.72M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $90.93M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $60.6M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $64.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $69.05M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $74.1M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $213.52M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $214.4M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $280.01M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $284.21M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.96M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $710K |
| Capex | Q1 2025 · Mar 31, 2024 | $1.84M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $7.28M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $210.96M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $201.48M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.76 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.76 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $119.35M |
| Net Income | Q1 2025 · Mar 31, 2024 | $8.32M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $7.94M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $127.29M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $47.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $174.74M |